The operation in Kabul, Afghanistan, is proving to be a significant participant in the regional supply market for Abacavir Sulphate drug substance. This local manufacturing potential represents a considerable step ahead for the Afghan pharmaceutical business and presents a distinct opportunity to lower dependence on overseas providers. The producti